BIOMARIN PHARMACEUTICALBIOMARIN PHARMACEUTICALBIOMARIN PHARMACEUTICAL

BIOMARIN PHARMACEUTICAL

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.31EUR
Revenue estimate
‪616.31 M‬EUR
Market capitalization
‪14.31 B‬EUR
‪151.89 M‬EUR
‪2.19 B‬EUR
‪185.93 M‬
Beta (1Y)
0.24

About BioMarin Pharmaceutical Inc.

CEO
Alexander Hardy
Headquarters
San Rafael
Employees (FY)
‪3.4 K‬
Founded
1997
FIGI
BBG01K3X4DP8
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 1BMRN is featured.

Frequently Asked Questions

The current price of 1BMRN is 76.76 EUR — it has increased by 0.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange BIOMARIN PHARMACEUTICAL stocks are traded under the ticker 1BMRN.
BIOMARIN PHARMACEUTICAL is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
1BMRN stock is 0.47% volatile and has beta coefficient of 0.24. Check out the list of the most volatile stocks — is BIOMARIN PHARMACEUTICAL there?
1BMRN earnings for the last quarter are 0.10 EUR per share, whereas the estimation was 0.18 EUR resulting in a −44.21% surprise. The estimated earnings for the next quarter are 0.29 EUR per share. See more details about BIOMARIN PHARMACEUTICAL earnings.
BIOMARIN PHARMACEUTICAL revenue for the last quarter amounts to ‪585.47 M‬ EUR despite the estimated figure of ‪578.78 M‬ EUR. In the next quarter revenue is expected to reach ‪604.10 M‬ EUR.
Yes, you can track BIOMARIN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
1BMRN stock has fallen by 8.05% compared to the previous week, the month change is a 6.12% fall, over the last year BIOMARIN PHARMACEUTICAL has showed a 3.25% decrease.
1BMRN net income for the last quarter is ‪82.17 M‬ EUR, while the quarter before that showed ‪18.46 M‬ EUR of net income which accounts for 345.13% change. Track more BIOMARIN PHARMACEUTICAL financial stats to get the full picture.
Today BIOMARIN PHARMACEUTICAL has the market capitalization of ‪14.36 B‬, it has decreased by 1.82% over the last week.
No, 1BMRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1BMRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARIN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
1BMRN reached its all-time high on Jan 3, 2024 with the price of 91.38 EUR, and its all-time low was 76.40 EUR and was reached on Apr 25, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪3.40 K‬ employees. See our rating of the largest employees — is BIOMARIN PHARMACEUTICAL on this list?
We've gathered analysts' opinions on BIOMARIN PHARMACEUTICAL future price: according to them, 1BMRN price has a max estimate of 130.94 EUR and a min estimate of 74.82 EUR. Read a more detailed BIOMARIN PHARMACEUTICAL forecast: see what analysts think of BIOMARIN PHARMACEUTICAL and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARIN PHARMACEUTICAL EBITDA is ‪300.06 M‬ EUR, and current EBITDA margin is 12.35%. See more stats in BIOMARIN PHARMACEUTICAL financial statements.